Valerie Nelson

805 total citations
26 papers, 579 citations indexed

About

Valerie Nelson is a scholar working on Oncology, Genetics and Pathology and Forensic Medicine. According to data from OpenAlex, Valerie Nelson has authored 26 papers receiving a total of 579 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 9 papers in Genetics and 6 papers in Pathology and Forensic Medicine. Recurrent topics in Valerie Nelson's work include Chronic Lymphocytic Leukemia Research (6 papers), Economic and Financial Impacts of Cancer (5 papers) and Lymphoma Diagnosis and Treatment (5 papers). Valerie Nelson is often cited by papers focused on Chronic Lymphocytic Leukemia Research (6 papers), Economic and Financial Impacts of Cancer (5 papers) and Lymphoma Diagnosis and Treatment (5 papers). Valerie Nelson collaborates with scholars based in United States, Brazil and United Kingdom. Valerie Nelson's co-authors include Al B. Benson, Chi Chen, Dan Yao, Alexa R. Weingarden, Michael J. Sadowsky, Aleh Bobr, Yuwei Lu, Alexander Khoruts, Alfred Rademaker and Cesar A. Santa‐Maria and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer Research.

In The Last Decade

Valerie Nelson

25 papers receiving 573 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Valerie Nelson United States	8	263	238	168	151	130	26	579
Sawan Bopanna India	19	170 0.6×	199 0.8×	108 0.6×	307 2.0×	471 3.6×	44	953
Sang‐Bum Kang South Korea	14	151 0.6×	66 0.3×	61 0.4×	99 0.7×	156 1.2×	52	489
Stephan Brackmann Norway	12	143 0.5×	52 0.2×	109 0.6×	239 1.6×	158 1.2×	24	536
Go Kuwata Japan	15	208 0.8×	159 0.7×	172 1.0×	199 1.3×	304 2.3×	32	646
Ansen B.P. Burr United States	8	229 0.9×	78 0.3×	138 0.8×	81 0.5×	49 0.4×	10	555
Michael May United States	12	131 0.5×	98 0.4×	151 0.9×	123 0.8×	114 0.9×	38	502
Mukesh Kumar Singh India	10	180 0.7×	116 0.5×	27 0.2×	116 0.8×	101 0.8×	43	464
Nirit Keren Israel	6	209 0.8×	44 0.2×	122 0.7×	56 0.4×	121 0.9×	7	348
Lani Prideaux Australia	11	265 1.0×	128 0.5×	45 0.3×	572 3.8×	333 2.6×	25	1.1k
Renyong Guo China	13	265 1.0×	82 0.3×	97 0.6×	188 1.2×	124 1.0×	24	635

Countries citing papers authored by Valerie Nelson

Since Specialization

Citations

This map shows the geographic impact of Valerie Nelson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Valerie Nelson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Valerie Nelson more than expected).

Fields of papers citing papers by Valerie Nelson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Valerie Nelson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Valerie Nelson. The network helps show where Valerie Nelson may publish in the future.

Co-authorship network of co-authors of Valerie Nelson

This figure shows the co-authorship network connecting the top 25 collaborators of Valerie Nelson. A scholar is included among the top collaborators of Valerie Nelson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Valerie Nelson. Valerie Nelson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Dixit, Karan, Sean Grimm, Rimas V. Lukas, et al.. (2024). A Phase II Trial of Bevacizumab in Patients with Recurrent/Progressive Solid Tumor Brain Metastases That Have Progressed Following Whole-Brain Radiation Therapy. Cancers. 16(11). 2133–2133. 2 indexed citations

2.

Karmali, Reem, Mehdi Hamadani, Leo I. Gordon, et al.. (2024). A phase 1-2 trial of DA-EPOCH-R plus ixazomib for MYC-aberrant lymphoid malignancies: the DACIPHOR regimen. Blood Advances. 8(7). 1612–1620. 2 indexed citations

3.

Karmali, Reem, Jeremy S. Abramson, Deborah M. Stephens, et al.. (2023). Ibrutinib maintenance after frontline treatment in patients with mantle cell lymphoma. Blood Advances. 7(23). 7361–7368. 3 indexed citations

4.

Swetzig, Wendy M., Valery Adorno-Cruz, Mario Javier Pineda, et al.. (2021). Efficacy and safety of tivozanib in recurrent, platinum-resistant ovarian, fallopian tube or primary peritoneal cancer, an NCCN phase II trial. Gynecologic Oncology. 163(1). 57–63. 5 indexed citations

5.

Weldon, Christine B., Julia R. Trosman, Al B. Benson, et al.. (2020). Promoting patient health maintenance with cancer care planning at diagnosis and during treatment: baseline data of the Coleman Supportive Oncology Collaborative (CSOC).. Journal of Clinical Oncology. 38(15_suppl). e24051–e24051. 1 indexed citations

6.

Shah, Ami N., Lisa Flaum, Irene Helenowski, et al.. (2020). Phase II study of pembrolizumab and capecitabine for triple negative and hormone receptor-positive, HER2−negative endocrine-refractory metastatic breast cancer. Journal for ImmunoTherapy of Cancer. 8(1). e000173–e000173. 75 indexed citations

7.

Kumthekar, Priya, Karan Dixit, Sean Grimm, et al.. (2019). A phase II trial of bevacizumab in patients with recurrent solid tumor brain metastases who have failed whole brain radiation therapy (WBRT).. Journal of Clinical Oncology. 37(15_suppl). 2070–2070. 5 indexed citations

8.

Monte, Daniel F. M., Valerie Nelson, Louise Cerdeira, et al.. (2019). Multidrug- and colistin-resistant Salmonella enterica 4,[5],12:i:- sequence type 34 carrying the mcr-3.1 gene on the IncHI2 plasmid recovered from a human. Journal of Medical Microbiology. 68(7). 986–990. 23 indexed citations

9.

Karmali, Reem, Jeremy S. Abramson, Deborah M. Stephens, et al.. (2019). Ibrutinib maintenance following induction for untreated mantle cell lymphoma (MCL): Initial safety report.. Journal of Clinical Oncology. 37(15_suppl). 7542–7542. 2 indexed citations

10.

Trosman, Julia R., Christine B. Weldon, Seema A. Khan, et al.. (2018). Results from a pilot of an innovative 4R Cancer Care Delivery Model: Impact on patient self-management.. Journal of Clinical Oncology. 36(30_suppl). 224–224. 1 indexed citations

11.

Trosman, Julia R., Christine B. Weldon, Seema A. Khan, et al.. (2018). Results from a pilot of an innovative 4R Cancer Care Delivery Model: Impact on patient self-management.. Journal of Clinical Oncology. 36(15_suppl). 6527–6527. 1 indexed citations

12.

Weldon, Christine B., Julia R. Trosman, Swati Kulkarni, et al.. (2018). Results from a pilot of an innovative 4R Cancer Care Delivery Model in early breast cancer: Impact on timing and sequencing of guideline recommended care.. Journal of Clinical Oncology. 36(15_suppl). 561–561. 2 indexed citations

13.

Trosman, Julia R., Christine B. Weldon, Swati Kulkarni, et al.. (2017). Written care plan and patient enablement: Pre-implementation data from the 4R in Oncology Project.. Journal of Clinical Oncology. 35(8_suppl). 55–55. 1 indexed citations

14.

Nelson, Valerie & Al B. Benson. (2016). Epidemiology of Anal Canal Cancer. Surgical Oncology Clinics of North America. 26(1). 9–15. 63 indexed citations

15.

Satin, David J., et al.. (2014). Ethics education in family medicine training in the United States: a national survey.. PubMed. 46(1). 28–35. 10 indexed citations

16.

Satin, David J., et al.. (2014). Ethics Education in Family Medicine Training in the United States. 1 indexed citations

17.

Nelson, Valerie & Al B. Benson. (2013). Pathological Complete Response After Neoadjuvant Therapy for Rectal Cancer and the Role of Adjuvant Therapy. Current Oncology Reports. 15(2). 152–161. 11 indexed citations

18.

Nelson, Valerie, Jessica K. Altman, & Leonidas C. Platanias. (2013). Next generation of mammalian target of rapamycin inhibitors for the treatment of cancer. Expert Opinion on Investigational Drugs. 22(6). 715–722. 17 indexed citations

19.

Nelson, Valerie & Al B. Benson. (2013). Status of targeted therapies in the adjuvant treatment of colon cancer.. PubMed. 4(3). 245–52. 16 indexed citations

20.

Weingarden, Alexa R., Chi Chen, Aleh Bobr, et al.. (2013). Microbiota transplantation restores normal fecal bile acid composition in recurrentClostridium difficileinfection. American Journal of Physiology-Gastrointestinal and Liver Physiology. 306(4). G310–G319. 320 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact